Onderzoeker
Lize Bollen
- Disciplines:Laboratoriumgeneeskunde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen, Medische biotechnologie, Farmaceutica, Ontdekking en evaluatie van geneesmiddelen
Affiliaties
- Therapeutische en Diagnostische Antilichamen (Afdeling)
Lid
Vanaf1 apr 2013 → 30 sep 2015
Projecten
1 - 1 of 1
- Rol van PAI-1 en TAFI in de aetiology van IBD en als prognostische merker en/of therapeutisch target om veneuze tromboembolisme in IBD patiënten te voorkomen.Vanaf1 okt 2011 → 30 sep 2015Financiering: FWO mandaten
Publicaties
1 - 10 van 11
- Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation(2016)
Auteurs: Thomas Van Stappen, Lize Bollen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
- Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profile(2016)
Auteurs: Lize Bollen, Joke Wuyts, Séverine Vermeire, Ann Gils
Pagina's: 223 - 5 - Analytical and clinical validation of a rapid point-of-care assay for infliximab quantification in patients with ulcerative colitis(2016)
Auteurs: Thomas Van Stappen, Lize Bollen, Niels Vande Casteele, Konstantinos Papamichael, Nick Geukens, Chris Barthel, Yessica Kölmel, Nasim Zali, Steffen Rameil, Gert Van Assche, et al.
Pagina's: S145 - S145 - Thromboembolism as an important complication of inflammatory bowel disease(2016)
Auteurs: Lize Bollen, Niels Vande Casteele, Vera Ballet, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: 1 - 7 - The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile(2015)
Auteurs: Lize Bollen, Niels Vande Casteele, Gert Van Assche, Marc Ferrante, Paul Declerck, Séverine Vermeire, Ann Gils
Pagina's: 2540 - 8 - Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease: A Prospective Study(2015)
Auteurs: Lize Bollen, Niels Vande Casteele, Kristel Van Steen, Paul Rutgeerts, Marc Ferrante, Marc Hoylaerts, Séverine Vermeire, Ann Gils
Pagina's: 570 - 8 - Active PAI-1 as marker for venous thromboembolism: Case-control study using a comprehensive panel of PAI-1 and TAFI assays(2014)
Auteurs: Lize Bollen, Marijke Peetermans, Kristel Van Steen, Marc Hoylaerts, Paul Declerck, Peter Verhamme, Ann Gils
Pagina's: 1097 - 102 - PRIMARY RESPONSE TO INFLIXIMAB THERAPY IN IBD PATIENTS IS REFLECTED IN THE NORMALISATION OF THE HAEMOSTATIC PROFILE(2014)
Auteurs: Lize Bollen, Niels Vande Casteele, M Peeters, Paul Declerck, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: S6 - S7 - ACTIVE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) CONCENTRATIONS ARE INCREASED IN PATIENTS WITH A VENOUS THROMBOEMBOLISM (VTE)(2014)
Auteurs: Lize Bollen, M Peeters, Marc Hoylaerts, Paul Declerck, Peter Verhamme, Ann Gils
Pagina's: S7 - S7 - Primary response to infliximab therapy in IBD patients is reflected in the normalisation of the haemostatic profile(2014)
Auteurs: Lize Bollen, Niels Vande Casteele, M Peeters, Paul Declerck, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: S221 - S222